Intronix Technologies Attending AAPM&R Event to Share Myoguide™, Latest Guided Injection System Breakthrough

News provided by

Aug 15, 2013, 08:21 ET

TORONTO, Aug. 15, 2013 /PRNewswire/ -- Leading medical equipment designer Intronix Technologies (http://www.intronixtech.com) will be on hand at the upcoming assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) to discuss the company's most recent advance in guided injection technology. The Myoguide™ Needle EMG Guided Injection System promises a safer and more effective means of delivering medication for the treatment of myofascial pain, spasticity and fibromyalgia. Currently, Myoguide™ is most frequently used with Botox® and similar drugs, although the potential applications for the system are numerous.

(Photo: http://photos.prnewswire.com/prnh/20130815/PH64653-a )
(Photo: http://photos.prnewswire.com/prnh/20130815/PH64653-b )

This year's AAPM&R Annual Assembly and Technical Exhibition (http://www.aapmr.org/assembly/Pages/default.aspx) will be held in National Harbor, Maryland at the Gaylord National Hotel and Convention Center. The event will feature guest speakers, presentations and hands-on workshops with some of the leading specialists in the field of physical medicine and rehabilitation; Intronix will be available in Booth 709.

For distribution in the United States, Intronix has partnered with global medical device supplier Ambu (http://www.ambuusa.com), another attendee of this year's event (Booth 724). Both companies will be discussing the many benefits of Myoguide™, along with the complementary products that improve device performance and help alleviate pain and discomfort.

"With Ambu on our team, Intronix can now provide clinician customers with Ambu's Neuroline hypodermic needle electrodes and surface electrode product lines," says Dr. Evan Friedman, president of Intronix Technologies. "At the AAPM&R event, attendees will discover that we're uniquely able to offer a complete clinical package for managing pain, movement disorders and spasticity—a convenient benefit for all. Ambu's robust distribution network will give Myoguide™ full exposure throughout the North American healthcare community."

Friedman continued: "We wish to extend an invitation to all attending clinicians and academics to visit us at Booth 709 to discuss the future of patient management. As a small company, we listen constantly, and we're always asking, 'how do we make this better, faster, less complicated, more reliable?' We always prioritize the application of our products, not just the theory, and look for the solutions, big and small, that make real differences for clinicians who treat injury or illness, non-surgically, to decrease pain and restore function."

The AAPM&R Annual Assembly and Technical Exhibition provides an exceptional opportunity for networking and education among physical medicine practitioners and medical device manufacturers. Among the elite biomedical firms attending this year's event are Botox® maker Allergan (Booth 701). This year's event is particularly special, as the Academy is celebrating its 75^th anniversary. Throughout its storied history, AAPM&R has been proud to represent medical specialists who are leading the way in treating illness and injury with non-surgical procedures.

A perennial attendee at the annual assembly, Intronix has established a sterling reputation as an innovative and responsive medical device designer. The AAPM&R event, among other significant trade shows, allows the company to speak directly to its customers and build upon that constructive feedback.

About Ambu

Ambu develops, produces and markets diagnostic and life-supporting devices for hospitals and rescue services. Its most notable products include artificial-respiration ventilation solutions and single-use electrodes for ECG tests and neurophysiological mappings. With corporate headquarters in Ballerup, Denmark and the United States headquarters in Glen Burnie, Md., Ambu employs approximately 1,700 people worldwide. For more information, visit www.ambuusa.com or contact Dan Toomey: [email protected].

About Intronix Technologies Corporation

Located just outside Toronto, Ontario, Intronix Technologies Corporation designs and produces progressive electromyographic (EMG) systems for applications in the diagnosis and management of myofascial pain, spasticity, and fibromyalgia. Its innovations in injection guidance provide technology that drives clinical solutions to deliver confidence, improve workflow efficiency, and provide a better patient experience. Intronix Technologies is known for its exceptional equipment, plus its comprehensive customer-support programs that are developed to maximize the lifecycle value of equipment through responsive service maintenance and significant software support. Learn more at http://www.intronixtech.com.

Contact:

Dr. Evan Friedman
President, Intronix Technologies Corporation
800-819-9996
Email